The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1159
June 23, 2003
View Complete Issue         Table of Contents 2019 
Prilosec, Nexium and Stereoisomers
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Prilosec, Nexium and Stereoisomers
June 23, 2003 (Issue: 1159)
Recently pharmaceutical manufacturers have marketed a stereoisomer of a successful drug nearing patent expiration as a new drug. Examples, such as esomeprazole (Nexium) , levalbuterol (Xopenex), escitalopram (Lexapro) and dexmethylphenidate
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Prilosec, Nexium and Stereoisomers
Article code: 1159c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.